Holen Sie sich die Stockscreener-App
91.34
1.29%
1.16
Schlusskurs vom Vortag:
$90.18
Offen:
$90
24-Stunden-Volumen:
906.98K
Relative Volume:
0.84
Marktkapitalisierung:
$12.39B
Einnahmen:
$2.94B
Nettoeinkommen (Verlust:
$537.87M
KGV:
23.22
EPS:
3.9341
Netto-Cashflow:
$579.02M
1W Leistung:
-3.72%
1M Leistung:
+4.10%
6M Leistung:
+51.25%
1J Leistung:
+28.45%
1-Tages-Spanne:
$89.16
$92.41
1-Wochen-Bereich:
$87.50
$95.68
52-Wochen-Spanne:
$51.79
$101.40
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
91.34 | 12.39B | 2.94B | 537.87M | 579.02M | 3.9341 |
ABT
Abbott Laboratories
|
89.46 | 155.82B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
294.73 | 112.88B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
80.00 | 102.71B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
56.50 | 83.97B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.98 | 48.42B | 6.30B | 1.07B | 1.34B | 1.8406 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Hochstufung | Needham | Hold → Buy |
| 2026-01-27 | Eingeleitet | TD Cowen | Buy |
| 2025-11-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-11-07 | Hochstufung | Truist | Hold → Buy |
| 2025-10-28 | Fortgesetzt | Stifel | Hold |
| 2025-05-27 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-01-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
Vanguard Group Inc. Cuts Stock Holdings in Globus Medical, Inc. $GMED - MarketBeat
A Look At Globus Medical (GMED) Valuation As Shares Show Mixed Short Term Momentum - Sahm
Precision Trading with Globus Medical Inc. Class A (GMED) Risk Zones - Stock Traders Daily
Globus Medical, Inc. $GMED Shares Purchased by Artemis Investment Management LLP - MarketBeat
Globus Medical, Inc. (NYSE:GMED) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Globus Medical, Inc. $GMED Shares Purchased by Comerica Bank - MarketBeat
Bares Capital Increases Stake in Surgical Powerhouse Globus Medical - HarianBasis.co
Globus Medical Inc. (GMED): Bares Capital Is Buying This Stock - Insider Monkey
Vanguard reports 5,885,560 shares in Globus Medical (NYSE: GMED) - Stock Titan
Globus Medical (GMED) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Short Interest in Globus Medical, Inc. (NYSE:GMED) Rises By 17.0% - MarketBeat
Globus Medical (GMED) to Release Quarterly Earnings on Thursday - MarketBeat
Globus Medical IncA (NYSE:GMED) Fits the Affordable Growth Profile - ChartMill
M&T Bank Corp Acquires 16,827 Shares of Globus Medical, Inc. $GMED - MarketBeat
GMED Stock Price, Quote & Chart | GLOBUS MEDICAL INCA (NYSE:GMED) - ChartMill
A Look at Globus Medical Inc (GMED) After 3.2% Decline -- GF Value $97.04 vs Price $90.74 - GuruFocus
Is It Time To Reassess Globus Medical (GMED) After Its Recent 1 Year Rally - Sahm
Medical Devices & SuppliesSpecialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz - Yahoo Finance
MERIDIAN GROWTH FUND's Globus Medical Inc(GMED) Holding History - GuruFocus
Zacks Research Forecasts Reduced Earnings for Globus Medical - MarketBeat
Globus Medical (NYSE: GMED) adds 1M shares to equity plan in 2026 shareholder vote - Stock Titan
Q1 EPS Estimates for Globus Medical Raised by Zacks Research - MarketBeat
Paradice Investment Management LLC Cuts Holdings in Globus Medical, Inc. $GMED - MarketBeat
GMED (Globus Medical Inc.) posts Q4 2025 EPS beat and 16.6 percent revenue growth, shares dip modestly.Social Investment Platform - Xã Thanh Hà
Globus Medical wins favorable jury verdict in patent dispute with Life Spine - MSN
Globus Medical to Report First-Quarter 2026 Results May 7 - MyChesCo
A Look At Globus Medical (GMED) Valuation After Recent Share Price Moves - Yahoo Finance
Boston Trust Walden Corp Purchases 182,526 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical Stock (GMED): A Comprehensive Guide to NYSE:GMED - Bitget
Globus Medical Inc (GMED) Stock Price, Trades & News - GuruFocus
Globus Medical Inc (GMED) Shares Fall 3.1% -- What GF Score of 9 - GuruFocus
Globus Medical Inc stock (US3795772082): Why Google Discover changes matter more now - AD HOC NEWS
US Medical Robotics Market is expected to Hit US$ 286.99 Million - openPR.com
PEEK Interbody Devices Market to Reach USD 4.76 Billion by 2033 - openPR.com
Globus Medical (GMED) Stock: Why Restructuring Benefit (Ticks Higher) 2026-04-20Wall Street Picks - Cổng thông tin điện tử tỉnh Lào Cai
Globus Medical, Inc. (GMED) Stock Analysis: Unpacking a 15.57% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Assessing Globus Medical (GMED) Valuation After Strong Recent Share Price Momentum - Sahm
Globus Medical (GMED) Is Up 5.3% After Robust Q1 Growth But Softer Returns On Capital - Sahm
Is It Too Late To Consider Globus Medical (GMED) After Strong Multi‑Year Share Price Gains - Sahm
Why Globus Medical (GMED) is a top momentum stock for the long term - MSN
Globus Medical, Inc. (NYSE:GMED) Sees Significant Decline in Short Interest - MarketBeat
GMED Stock Chart | GLOBUS MEDICAL INCA (NYSE:GMED) - ChartMill
Globus Medical Schedules First Quarter Earnings Release and Conference Call - GlobeNewswire
Massachusetts Financial Services Co. MA Has $22.82 Million Stake in Globus Medical, Inc. $GMED - MarketBeat
Why Globus Medical (GMED) is a Top Momentum Stock for the Long-Term - Yahoo Finance
2 Reasons to Like GMED and 1 to Stay Skeptical - Yahoo Finance
Wells Fargo initiates coverage of Globus Medical (GMED) with an overweight rating - MSN
235,617 Shares in Globus Medical, Inc. $GMED Acquired by Annex Advisory Services LLC - MarketBeat
Globus Medical (GMED) Gets a Buy from RBC Capital - The Globe and Mail
Globus medical outlines $2.8B-$2.9B 2025 revenue guidance amid Nevro integration - MSN
[144] GLOBUS MEDICAL INC SEC Filing - Stock Titan
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.57%
1.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):